Provided by Tiger Trade Technology Pte. Ltd.

Veru Inc.

2.34
+0.10004.46%
Volume:65.46K
Turnover:152.74K
Market Cap:37.56M
PE:-1.51
High:2.37
Open:2.24
Low:2.21
Close:2.24
52wk High:7.40
52wk Low:2.10
Shares:16.05M
Float Shares:14.48M
Volume Ratio:0.54
T/O Rate:0.45%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.5517
EPS(LYR):-1.5517
ROE:-61.92%
ROA:-49.21%
PB:2.05
PE(LYR):-1.51

Loading ...

Company Profile

Company Name:
Veru Inc.
Exchange:
NASDAQ
Establishment Date:
1971
Employees:
20
Office Location:
2916 North Miami Avenue,Suite 1000,Miami,Florida,United States
Zip Code:
33127
Fax:
- -
Introduction:
Veru Inc., a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). Its marketed products comprise FC2 female condom for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections. The company's development program includes enobosarm, a selective androgen receptor modulator for treatment of augment fat loss and to prevent muscle loss in sarcopenic obese and overweight elderly patients; Enobosarm, a selective androgen receptor modulator for the treatment of AR+ ER+ HER2- metastatic breast cancer; and sabizabulin, a microtubule disruptor for the treatment of hospitalized patients with viral lung infection on oxygen support who are at high risk for viral induced ARDS and death. The company was formerly known as The Female Health Company and changed its name to Veru Inc. in July 2017. Veru Inc. was incorporated in 1971 and is headquartered in Miami, Florida.

Directors

Name
Position
Harry Fisch
Chief Corporate Officer and Director and Vice Chairman
Mitchell S. Steiner
Chairman of the Board and Chief Executive Officer and Director and President
Grace Hyun
Director
Loren Katzovitz
Director
Lucy Lu
Director
Michael L. Rankowitz
Director

Shareholders

Name
Position
Mitchell S. Steiner
Chairman of the Board and Chief Executive Officer and Director and President
Michele Greco
Chief Administrative Officer and Chief Financial Officer
Harry Fisch
Chief Corporate Officer and Director and Vice Chairman
K. Gary Barnette
Chief Scientific Officer